Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To evaluate if treatment with Lixisenatide for 24 weeks reduces Ao-PWV in T2DM with DN.
Critère d'inclusion
- Type 2 Diabetes
To evaluate if treatment with Lixisenatide for 24 weeks reduces Ao-PWV in T2DM with DN.